- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07458165
From a Single Child to Family Planning (FromSich)
March 7, 2026 updated by: Michele Tedeschi, Istituto Clinico Humanitas
From Single Child to Family Planning: Determinants of Returning to ART to Build the Desired Family in a Monocentric Italian Cohort.
This monocentric retrospective cohort study aims to investigate reproductive behavior and subsequent family-building outcomes in couples who achieved a first live birth through assisted reproductive technology (ART) at a university-affiliated fertility center in Italy.
All couples obtaining a first live birth between January 2010 and December 2020 will be included and followed until December 2024.
The primary objective is to evaluate the rate of return for further ART treatment after the first live birth.
Secondary objectives include assessing cumulative live birth rate (CLBR) for the second and third live birth.
Associations between return behavior and clinical factors, including maternal age, presence of cryopreserved oocytes or embryos, and treatment characteristics, will be analyzed.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
5852
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
The study included all couples who underwent and completed ART cycles and achieved a first live birth between January 2010 and December 2020, who subsequently returned for new attempts, and met the following inclusion criteria: being a heterosexual couple with maternal age between 18 and 43 years, having complete clinical and demographic data available in the internal database, and having follow-up information up to December 2024
Description
Inclusion Criteria:
- Copules underwent ART treatment at the Humanitas Fertility Center (Rozzano, Milan)
- Copules achieved a first clinical pregnancy resulting from ART between January 2010 and December 2020
- heterosexual couples in which the maternal age was between 18 and 43 years old
Exclusion Criteria:
- Couples who did not meet the inclusion criteria
- ART cycles involving preimplantation genetic testing for aneuploidy (PGT-A)
- Use of donor gametes (oocyte or sperm donation)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Non-returners
Couples who achieved a first live birth through ART at the study center and did not return for further ART treatment after the index birth during the follow-up period.
|
|
Returners
Couples who achieved a first live birth through ART at the study center and subsequently returned to undergo one or more additional ART cycles for further reproductive attempts during follow-up.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Return rate of couples who had achieved a first pregnancy and returned to pursue a second child.
Time Frame: From January 2010 to December 2024
|
Analysis of the return rate of couples who had already achieved a first pregnancy and pursued a second child, with a comprehensive evaluation of the clinical, demographic, and treatment-related factors that may influence their likelihood of returning for additional ART attempts.
This analysis aims to identify which characteristics are associated with a higher or lower probability of continuing their family-building journey after the initial live birth.
|
From January 2010 to December 2024
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cumulative live birth rate of couples who had already achieved a first live birth and attempted to conceive a second child
Time Frame: From January 2010 to December 2024
|
Analysis of the cumulative live birth rate of couples who had already achieved a first live birth and pursued a second child through subsequent ART attempts, with a comprehensive evaluation of the clinical, demographic, and treatment-related factors that may influence their probability of achieving an additional live birth.
This analysis aims to identify which characteristics are associated with higher or lower chances of successfully obtaining a second live birth after the initial one
|
From January 2010 to December 2024
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2010
Primary Completion (Actual)
December 31, 2024
Study Completion (Actual)
December 31, 2024
Study Registration Dates
First Submitted
March 3, 2026
First Submitted That Met QC Criteria
March 3, 2026
First Posted (Actual)
March 9, 2026
Study Record Updates
Last Update Posted (Actual)
March 10, 2026
Last Update Submitted That Met QC Criteria
March 7, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- GIN2/OSS001/2025
- Ethics committee No. 4773 (Other Identifier: Humanitas Research Hospital)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Individual participant data will not be shared due to the retrospective design of the study and institutional data protection policies.
Only aggregated, anonymized results will be made available in the published manuscript.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility Assisted Reproductive Technology
-
Reproductive & Genetic Hospital of CITIC-XiangyaThe First People's Hospital of Yunnan; Nanjing Women and Children's Healthcare... and other collaboratorsNot yet recruitingInfertility Assisted Reproductive TechnologyChina, Argentina, Malaysia, South Korea, Spain
-
University Hospital, GhentFertiga, BelgiumRecruitingInfertility Assisted Reproductive TechnologyBelgium
-
Central Hospital, Nancy, FranceNot yet recruitingEgg Donation | Infertility Assisted Reproductive TechnologyFrance
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
-
McGill University Health Centre/Research Institute...Not yet recruitingInfertility | Assisted Reproductive Technology OutcomesCanada
-
Marmara UniversityNot yet recruitingInfertility | Self-Efficacy | Assisted Reproductive Technology | Infertility in Women Undergoing Assisted Reproductive Treatment | Health Lifestyle BehaviorsTurkey (Türkiye)
-
Merck KGaA, Darmstadt, GermanyMerck Serono GmbH, Germany; Merck B.V., Netherlands; Merck A.E., Greece; Merck... and other collaboratorsCompletedAssisted Reproductive Techniques | Reproductive Technology, AssistedItaly, Russian Federation, United Kingdom, Germany, Poland, Finland, Slovakia, Netherlands, Denmark, France, Greece
-
McGill University Health Centre/Research Institute...RecruitingInfertility | Sexual Behavior | Sexual Function | Assisted Reproductive Techniques | Sexual Dysfunction Female | Sexual Dysfunction and Infertility | Infertility Assisted Reproductive TechnologyCanada
-
Reproductive & Genetic Hospital of CITIC-XiangyaWest China Hospital; Central South UniversityActive, not recruitingInfertility | Assisted Reproductive Technology
-
Royal Fertility Center, EgyptHawaa Fertility CenterCompletedInfertility | Assisted Reproductive TechnologyEgypt